Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories View More Recent Stories
-
Form SC 13G Kyverna Therapeutics, Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A NaaS Technology Inc. Filed by: Bain Capital Rise Education IV Cayman Ltd
-
Bain Capital Credit Announces $2 Billion of Financing Investments in 2023
-
Form 13F-HR Bain Capital Public Equi For: Dec 31
-
Form 13F-HR Bain Capital Public Equi For: Dec 31
-
Form 13F-HR Bain Capital Credit, LP For: Dec 31
-
Form SC 13G/A Bain Capital Specialty Filed by: BANK OF AMERICA CORP /DE/
-
Form SC 13G/A AvidXchange Holdings, Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.
-
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
-
Form SC 13G/A Flywire Corp Filed by: BAIN CAPITAL VENTURE FUND 2014, L.P.
-
Form SC 13G/A Canada Goose Holdings Filed by: Bain Capital Integral Investors 2008, L.P.
-
Form SC 13G/A Annexon, Inc. Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form SC 13G/A Disc Medicine, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A Cara Therapeutics, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SC 13G/A Cabaletta Bio, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Partners For: Dec 31
-
Form 13F-NT Bain Capital Fund XI, For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Venture For: Dec 31
-
Form 13F-HR BAIN CAPITAL INVESTORS For: Dec 31
-
Form 13F-NT Bain Capital Venture For: Dec 31
-
Form 13F-NT BAIN CAPITAL VENTURE For: Dec 31
-
Form 13F-HR BAIN CAPITAL VENTURE For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT Bain Capital Life Scienc For: Dec 31
-
Form 13F-HR Bain Capital Life Scienc For: Dec 31
-
Form 13F-NT BAIN CAPITAL VENTURE For: Dec 31
-
Form 13F-NT Bain Capital Fund XII, For: Dec 31
-
Form 13F-NT Bain Capital Partners For: Dec 31
-
Bain Capital Real Estate and Cherry Tree Capital Partners Form Joint Venture to Develop Rental Townhome Communities in Southern California
-
Hometap Surpasses $1 Billion in Home Equity Investments
-
EyeBio Announces Positive Visual, Anatomic and Safety Data from First-in-Human Ph1b/2a AMARONE Trial of Restoret at Macula Society Annual Meeting
-
Keap Hosts the Growth & Freedom Summit to Encourage Entrepreneurs to Conquer the Chaos
-
Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma
-
Trullion Supports Geographic Expansion Welcoming Four New Leaders
-
Form SC 13G/A TALOS ENERGY INC. Filed by: Bain Capital Credit Managed Account (E), L.P.
-
Ryze Claim Solutions Partners with Bain Capital Insurance to Support Continued Organic Growth and Launch Strategic Acquisition Initiative
-
Japan chipmaker Kioxia reports $434 million Q3 loss
-
AM Best Removes From Under Review With Negative Implications and Affirms Credit Ratings of GuideOne Insurance Companies’ Members
-
TeachTown enCORE Receives Double Honors from Tech & Learning Awards of Excellence: Best of 2023
-
UPDATE: Flood Raises $5.2 Million Seed Round to Democratize Ethereum’s Order Execution Led by Bain Capital Crypto
-
Flood Raises $5.2 Million Seed Round to Democratize Ethereum’s Order Execution Led by Bain Capital Crypto and Archetype
-
Form 3 Kyverna Therapeutics, For: Feb 07 Filed by: Bain Capital Life Sciences Investors, LLC
-
Tideline and Impact Capital Managers Publish Research on Cutting Edge Approaches to Investor Value Creation, Showing How Impact Can Drive Financial Outperformance
